Evidence map›Paper›PMID 38074503›Full record

ArticleJHEP reports : innovation in hepatology2024

Liver transplant selection criteria and outcomes in critically ill patients with ACLF.

Sophie-Caroline- Sacleux, Philippe Ichaï, Audrey Coilly, Marc Boudon, Elise Lemaitre, Rodolphe Sobesky, Eleonora De Martin, Valérie Cailliez, Ilias Kounis, Edoardo Poli and 10 more

Abstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Review
  4. Review
  5. Liver Transplantation in the Context of Acute-On-Chronic Liver Failure (ACLF): Where Do We Stand in 2025?Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sophie-Caroline- SacleuxAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Philippe IchaïAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Audrey CoillyAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Marc BoudonAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Elise LemaitreAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Rodolphe SobeskyAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Eleonora De MartinAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Valérie CailliezAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Ilias KounisAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Edoardo PoliAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Marie-Amélie OrdanAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Alina PascaleAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Jean-Charles Duclos-ValléeAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Cyrille FerayAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Daniel AzoulayAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Eric VibertAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Daniel CherquiAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
René AdamAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Didier SamuelAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.
Faouzi SalibaAP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire, Villejuif, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Aims: Retrospective studies have reported good results with liver transplantation (LTx) for acute-on-chronic liver failure (ACLF) in selected patients. The aim of this study was to evaluate the selection process for LTx in patients with ACLF admitted to the intensive care unit (ICU) and to assess outcomes. Methods: This prospective, non-interventional, single high-volume center study collected data on patients with ACLF admitted to the ICU between 2017-2020. Results: Among 200 patients (mean age: 55.0 ± 11.2 years and 74% male), 96 patients (48%) were considered potential candidates for LTx. Unfavourable addictology criteria (n = 76) was the main reason for LTx ineligibility. Overall, 69 patients were listed for LTx (34.5%) and 50 were transplanted (25% of the whole population). The 1-year survival in the LTx group was significantly higher than in the non-transplanted group (94% Conclusion: This prospective analysis of outcomes of patients with ACLF admitted to the ICU highlights the drastic nature of selection in this setting. Unfavourable addictology criteria, mechanical ventilation and increasing number of organ failures since admission were predictive of absence of LTx, futility and death. Impact and implications: Liver transplantation (LT) is the best therapeutic option in selected cirrhotic patients admitted to the ICU with acute on chronic liver failure. However, the selection criteria are poorly described and based on retrospective studies. This is the first prospective study that aimed to describe the selection process for LT in a transplant center. Patients with ACLF should be admitted to the ICU and evaluated within a short period of time for LT. In the context of organ shortage, eligibility for LT and either absence of LT, futility of care or death are better clarified in our study. These are mainly determined by prolonged respiratory failure and worsening of organ failures since ICU admission. Considering worldwide variations in the etiology and definition of ACLF, transplant availability and a narrow therapeutic window for transplant further prospective studies are awaited.

Indexed as

Acute-on-Chronic Liver FailureIntensive Care UnitLiver CirrhosisLiver transplantationMultiple Organ FailurePrognosisWaiting List

Identifiers

PMID38074503
PMCPMC10703599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.